Recently, molecular analyses of invasive lobular carcinomas established that these tumors have a distinct genomic profile compared to IBC-NST, exhibiting a high frequency of CDH1 mutations, loss of PTEN, activation of AKT, and mutations in TBX3 and FOXA1 [29, 30]. This evidence concerns the gene FOXA1 and invasive lobular breast carcinoma.